1995
DOI: 10.1039/an9952002185
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous determination of pseudouridine, neopterine and creatinine in urine by ion-pair high-performance liquid chromatography with in-series ultraviolet and fluorescence detection

Abstract: A simple, fast and precise method for the simultaneous determination of neopterine (Npt), pseudouridine (Psu) and creatinine (Cre) in urine by using ion-pair HPLC has been developed. The urine specimen is subjected to a microcolumn clean-up step, providing a ten-fold sample dilution, and is then injected into the column. The eluate is forced through the respective cells of a fluorescence and then a UV detector, which are connected in series. Neopterine is monitored by fluorescence emission at 438 nm (excitatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

1997
1997
2004
2004

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 9 publications
0
7
0
Order By: Relevance
“…Urine creatinine was used to normalize the urine concentrations of enrofloxacin and ciprofloxacin (Palmisano et al, 1995). This approach eliminates the problem of contamination with drinking water.…”
Section: Methodsmentioning
confidence: 99%
“…Urine creatinine was used to normalize the urine concentrations of enrofloxacin and ciprofloxacin (Palmisano et al, 1995). This approach eliminates the problem of contamination with drinking water.…”
Section: Methodsmentioning
confidence: 99%
“…[15][16][17] The role of modified nucleosides as tumour markers is widely recognised. [18][19][20][21] Increased levels of 5-methyl-2'-deoxycytidine (m 5 dCyd), a modified nucleoside probably derived from DNA, were recently detected in urine of leukaemia patients, for the first time, by an inhibition ELISA method. 22 Thus m 5 dCyd was proposed to be a new marker for the leukaemia disease.…”
mentioning
confidence: 99%
“…[1][2][3][4][5] Various methods have been developed for quantifying modified nucleosides, based on an enzyme-linked immunosorbent assay (ELISA), 6,7 32 P-post-labelling, 8 capillary electrophoresis, 9,10 HPLC with photodiode array detection 11,12 or ECD, 13 and GC/MS. [14][15][16] However, GC/MS analysis faced additional problems in the hydrolysis and derivatization steps.…”
mentioning
confidence: 99%